Navigation Links
New Data on Patient-Reported Improvements in Quality of Life Measures and Other Clinical Responses in Moderate to Severe Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol) Highlighted at American College of Rheumatology Meeting
Date:11/7/2011

ZIA, 4% placebo). The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 8% for CIMZIA and 7% for placebo.

In controlled RA clinical trials, the most common adverse events that occurred in greater than or equal to 3% of patients taking CIMZIA 200 mg every other week with concomitant methotrexate (n=640) and more frequently than with placebo with concomitant methotrexate (n=324) were upper respiratory tract infection (6% CIMZIA, 2% placebo), headache (5% CIMZIA, 4% placebo), hypertension (5% CIMZIA, 2% placebo), nasopharyngitis (5% CIMZIA, 1% placebo), back pain (4% CIMZIA, 1% placebo), pyrexia (3% CIMZIA, 2% placebo), pharyngitis (3% CIMZIA, 1% placebo), rash (3% CIMZIA, 1% placebo), acute bronchitis (3% CIMZIA,1% placebo), fatigue (3% CIMZIA, 2% placebo). Hypertensive adverse reactions were observed more frequently in patients receiving CIMZIA than in controls.  These adverse reactions occurred more frequently among patients with a baseline history of hypertension and among patients receiving concomitant corticosteroids and non-steroidal anti-inflammatory drugs.  Patients receiving CIMZIA 400mg as monotherapy every 4 weeks in RA controlled clinical trials had similar adverse reactions to those patients receiving CIMZIA 200mg every other week.  The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 5% for CIMZIA and 2.5% for placebo.

Please see full prescribing information at www.cimzia.com before prescribing.

For further Information:
Andrea Levin, Senior Manager, Communications & PR
(770) 970-8352, Andrea.Levin@ucb.com

Dena Koklanaris, Cooney/Waters Group
(212) 886-2228, DKoklanaris@cooneywate
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
2. QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities
3. NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
4. Reportlinker Adds Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
5. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
6. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
7. Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
8. Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinsons Disease
9. Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital
10. Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months
11. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... of the "Global Pharma US & EU ... Plays Major Role In Shaping Up Business for ... offering. Strategy Diversification Divested: Productivity ... Cash position- Will accelerate Next wave of targeted ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research and ... addition of the "Global Rising Stars Outlook 2015" ... Therapies for treating diseases are being sought after with ... is discovered. One field which is poised to bring ... in the next decades is the Stem cell therapy/Regenerative ...
(Date:3/5/2015)... COPENHAGEN, Denmark , March 5, 2015 /PRNewswire/ ... company that applies its innovative TransCon technology to ... will present two posters at the ENDO 2015 ... Center.  The posters will be presented on Thursday, ... that is being held from 1:00pm-3:00pm PST, and ...
Breaking Medicine Technology:Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3Global Pharma Rising Stars Outlook 2015 2Ascendis Pharma to Present at ENDO 2015 2
... Jan. 28 Repligen Corporation (Nasdaq: RGEN ... with GE Healthcare Bio-Sciences AB by entering into a five-year ... the manufacture of monoclonal antibodies, a highly successful class of ... A and has manufactured recombinant Protein A for GE Healthcare ...
... , , , ... 9th year, the ePharma,Summit ( http://www.epharmasummit.com ), to be held ... PA ,continues to be the most,innovative digital marketing event ... from leading pharmaceutical,companies attend ePharma Summit for incomparable access to ...
Cached Medicine Technology:Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A 2Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A 3MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010 2MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010 3
(Date:3/5/2015)... Supply & Demand Chain Executive Magazine has ... Know” in the supply chain industry, and we are ... team were included on this year’s list! Russ King ... due to their hard work, their commitment to excellence, ... resolving client needs and challenges. , Russ ...
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic ... Festival and Arnold Fitness EXPO in Columbus, ... host a display booth featuring free samples of its ... highly-popular, class-leading fat burner Synedrex. The company will also ... utilize its top-of-the-line supplements and miniature action figures of ...
(Date:3/5/2015)... Think it’s tough to get kids to eat their ... brush their teeth. That’s a finding from a new survey ... in conjunction with National Parenting Month in March. , ... brush their teeth is one of the most challenging things ... getting children to eat vegetables regularly (42 percent) or getting ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 The recent ... weight loss promises is alarming, with more and more ... without an actual prescription, making it easy for more ... simply take their money and endanger their health. The ... before purchasing prescription online diet pills: , 1.    Where are ...
(Date:3/5/2015)... MTC 5-day Fundamental Implantology Course has been developed by ... dental disciplines, to offer implant placement treatment to their ... wanted this course to be a truly empowering experience ... the lecturers and the sheer energy and enthusiasm of ... aims." , Unlike large-scale training operations, the MTC ...
Breaking Medicine News(10 mins):Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 2Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 3Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2
... cardiovascular damage , , WEDNESDAY, Nov. 12 (HealthDay News) -- ... vest" to determine that individual exposure to air pollution ... that community-level exposure can cause. , "The challenge ... to and what most studies talk about . . ...
... published in the,journal, Drug and Alcohol Dependence, warned ... product warning labels be made,mandatory., Symptoms of ... or daily headaches., The "boost" from energy ... sugar they contain. An 8.3-ounce, popular energy drink ...
... First member satisfaction survey shows health improvements, disease ... among valued benefits of plan -, ATLANTA, Nov. 12 ... and Georgia, 92 percent of members of Care,Improvement Plus feel ... examining the satisfaction of the plan,s southeast regional,membership. Of those ...
... Shows Vast Majority of Seniors Satisfied with Medicare Drug,Benefit, ... a national campaign to raise awareness about the 2009,Medicare ... 15 to December 31, 2008., The campaign is ... plans under Medicare,s Part D program if they have ...
... Germany, Nov. 12 As the exclusive official,breaking ... MEDICA,2008, November 19-22, PR Newswire is featuring profiles ... follows below., Company: Defibtech, LLC, Booth ... Defibtech, LLC is a leading innovator in ...
... - First member satisfaction survey shows health improvements, disease ... support among valued benefits of plan -, ST. LOUIS, ... Arkansas and Missouri, 90 percent of members of Care,Improvement Plus ... survey examining the satisfaction of the plan,s south central,regional membership. ...
Cached Medicine News:Health News:Vest Monitors 'Individual' Air Pollution 2Health News:Vest Monitors 'Individual' Air Pollution 3Health News:Study Calls for Labeling of Potentially Dangerous Energy Drinks 2Health News:Georgia and South Carolina Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan 2Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 2Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 3Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 4Health News:Defibtech, LLC Exhibiting at MEDICA 2008 2Health News:Arkansas and Missouri Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan 2
... BladderScan® BVI 6400 calculates bladder volume ... V-MODE® ultrasound is accurate, fast, and ... BladderScan® measures ultrasonic reflections within the ... a 3-dimensional image of the bladder, ...
... Contigen Bard Collagen Implant, the world's ... implant option for the treatment of Stress ... bulk to surrounding urethral tissue to aid ... with the body's own structure, Contigen Bard ...
... Wire Coil and helix provide distal ... Silver Wire Construction eliminates springback and ... is designed to provide a better ... result. ,Trimmable ends provide ...
... The Alpha I continues to be a ... the Alpha I to have mechanical reliability ... on first-time implants. ioflex material contributes to ... I. Thats because Bioflex: ,Provides maximum, controlled ...
Medicine Products: